Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1905 1
1908 1
1912 1
1913 1
1917 1
1919 1
1922 1
1923 2
1924 1
1925 2
1926 5
1927 2
1928 5
1929 1
1930 4
1932 2
1934 2
1935 3
1936 1
1937 1
1938 1
1939 3
1940 2
1941 2
1942 2
1943 4
1944 3
1945 26
1946 99
1947 129
1948 118
1949 130
1950 198
1951 200
1952 202
1953 215
1954 237
1955 227
1956 264
1957 242
1958 293
1959 221
1960 249
1961 302
1962 333
1963 623
1964 1138
1965 890
1966 1114
1967 1533
1968 2084
1969 2252
1970 2288
1971 2579
1972 2657
1973 2697
1974 2791
1975 2769
1976 2494
1977 2535
1978 2458
1979 2841
1980 3006
1981 3062
1982 3325
1983 3462
1984 3672
1985 3790
1986 3798
1987 3817
1988 4056
1989 4307
1990 4513
1991 4720
1992 4743
1993 4960
1994 5064
1995 5061
1996 5216
1997 5509
1998 5685
1999 5985
2000 6591
2001 6927
2002 7703
2003 8206
2004 9114
2005 10626
2006 11603
2007 12409
2008 13592
2009 14850
2010 15619
2011 16981
2012 18276
2013 19822
2014 20936
2015 21837
2016 22403
2017 23023
2018 23804
2019 24589
2020 27252
2021 28760
2022 27584
2023 25447
2024 8965

Text availability

Article attribute

Article type

Publication date

Search Results

501,357 results

Results by year

Filters applied: . Clear all
Page 1
Testosterone replacement therapy and cardiovascular risk.
Gagliano-Jucá T, Basaria S. Gagliano-Jucá T, et al. Nat Rev Cardiol. 2019 Sep;16(9):555-574. doi: 10.1038/s41569-019-0211-4. Nat Rev Cardiol. 2019. PMID: 31123340 Review.
However, no trials of testosterone replacement therapy published to date were designed or adequately powered to assess cardiovascular events; therefore, the cardiovascular safety of this therapy remains unclear. In this Review, we provide an overview of epide …
However, no trials of testosterone replacement therapy published to date were designed or adequately powered to assess cardiovascular …
Clinical and Imaging Indicators of Hemorrhagic Transformation in Acute Ischemic Stroke After Endovascular Thrombectomy.
Tian B, Tian X, Shi Z, Peng W, Zhang X, Yang P, Li Z, Zhang X, Lou M, Yin C, Zhang Y, Lu J, Liu J; DIRECT-MT Investigators. Tian B, et al. Stroke. 2022 May;53(5):1674-1681. doi: 10.1161/STROKEAHA.121.035425. Epub 2021 Dec 7. Stroke. 2022. PMID: 34872341 Clinical Trial.
BACKGROUND: Prior studies have investigated the clinical and imaging factors for hemorrhagic transformation (HT), especially symptomatic intracranial hemorrhage (sICH); however, whether alteplase increases the risk of HT after endovascular thrombectomy (EVT) is unkn …
BACKGROUND: Prior studies have investigated the clinical and imaging factors for hemorrhagic transformation (HT), especially symptoma …
Energy Drinks Induce Acute Cardiovascular and Metabolic Changes Pointing to Potential Risks for Young Adults: A Randomized Controlled Trial.
Basrai M, Schweinlin A, Menzel J, Mielke H, Weikert C, Dusemund B, Putze K, Watzl B, Lampen A, Bischoff SC. Basrai M, et al. J Nutr. 2019 Mar 1;149(3):441-450. doi: 10.1093/jn/nxy303. J Nutr. 2019. PMID: 30805607 Free article. Clinical Trial.
BACKGROUND: Case reports suggest a link between energy drinks (EDs) and adverse events, including deaths. OBJECTIVES: We examined cardiovascular and metabolic effects of EDs and mixtures providing relevant ingredients of EDs compared to a similarly composed control …
BACKGROUND: Case reports suggest a link between energy drinks (EDs) and adverse events, including deaths. OBJECTIVES: We examined …
Hypothermia.
Turk EE. Turk EE. Forensic Sci Med Pathol. 2010 Jun;6(2):106-15. doi: 10.1007/s12024-010-9142-4. Epub 2010 Feb 12. Forensic Sci Med Pathol. 2010. PMID: 20151230 Review.
SGLT2i: beyond the glucose-lowering effect.
Ni L, Yuan C, Chen G, Zhang C, Wu X. Ni L, et al. Cardiovasc Diabetol. 2020 Jun 26;19(1):98. doi: 10.1186/s12933-020-01071-y. Cardiovasc Diabetol. 2020. PMID: 32590982 Free PMC article. Review.
Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glucose by inhibiting its reabsorption in proximal tubules and by promoting urinary glucose excretion. SGLT2i are widely used in the …
Sodium/glucose cotransporter-2 inhibitors (SGLT2i) are a new type of glucose-lowering drug that can reduce blood glu …
Glucose control independent mechanisms involved in the cardiovascular benefits of glucagon-like peptide-1 receptor agonists.
Wu Q, Li D, Huang C, Zhang G, Wang Z, Liu J, Yu H, Song B, Zhang N, Li B, Chu X. Wu Q, et al. Biomed Pharmacother. 2022 Sep;153:113517. doi: 10.1016/j.biopha.2022.113517. Epub 2022 Aug 10. Biomed Pharmacother. 2022. PMID: 36076602 Free article. Review.
Patients with type 2 diabetes mellitus (T2DM) face a high risk of developing cardiovascular diseases. ...In this review, we systematically summarize the mechanisms of action of GLP-1RAs responsible for producing favorable effects on the cardiovascular …
Patients with type 2 diabetes mellitus (T2DM) face a high risk of developing cardiovascular diseases. ...In this review …
The storage lesions: From past to future.
Tissot JD, Bardyn M, Sonego G, Abonnenc M, Prudent M. Tissot JD, et al. Transfus Clin Biol. 2017 Sep;24(3):277-284. doi: 10.1016/j.tracli.2017.05.012. Epub 2017 Jun 30. Transfus Clin Biol. 2017. PMID: 28673502 Review.
Red blood cell (RBC) concentrates are stored in additive solutions at 4(o)C for up to 42 days, whereas platelets concentrates (PCs) are stored at 22(o)C with continuous agitation for up to 5 to 7 days, according national regulations, and the use or not of pathogen inactiva …
Red blood cell (RBC) concentrates are stored in additive solutions at 4(o)C for up to 42 days, whereas platelets concentrates (PCs) a …
The Changing Landscape of Pharmacotherapy for Diabetes Mellitus: A Review of Cardiovascular Outcomes.
Wu L, Gunton JE. Wu L, et al. Int J Mol Sci. 2019 Nov 21;20(23):5853. doi: 10.3390/ijms20235853. Int J Mol Sci. 2019. PMID: 31766545 Free PMC article. Review.
The prevention of cardiovascular morbidity and mortality has always been a primary concern in patients with type 2 diabetes. ...Whilst the data on the efficacy of intensive glucose lowering on reducing cardiovascular risk are limited, there are now inc …
The prevention of cardiovascular morbidity and mortality has always been a primary concern in patients with type 2 diabetes. . …
Hematoma Expansion: Clinical and Molecular Predictors and Corresponding Pharmacological Treatment.
Wang G, Zhang J. Wang G, et al. Curr Drug Targets. 2017;18(12):1367-1376. doi: 10.2174/1389450117666160712092224. Curr Drug Targets. 2017. PMID: 27411712 Review.
BACKGROUND: Hematoma expansion is a detrimental event of intracerebral hemorrhage (ICH) which results in progressive neurologic deteriorations and poor outcomes. ...RESULTS: Although the exact mechanism of hematoma expansion is unclear, accumulating ev …
BACKGROUND: Hematoma expansion is a detrimental event of intracerebral hemorrhage (ICH) which results in progressive ne …
Association between high serum blood glucose lymphocyte ratio and all-cause mortality in non-traumatic cerebral hemorrhage: a retrospective analysis of the MIMIC-IV database.
Yang S, Liu Y, Wang S, Cai Z, Yang A, Hui X. Yang S, et al. Front Endocrinol (Lausanne). 2023 Nov 29;14:1290176. doi: 10.3389/fendo.2023.1290176. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38093959 Free PMC article.
BACKGROUND: This study aimed to evaluate the association between the glucose-to-lymphocyte ratio (GLR) and all-cause mortality in intensive care unit (ICU) patients with Non-traumatic cerebral hemorrhage. ...Baseline data and in-hospital prognosis from patients with …
BACKGROUND: This study aimed to evaluate the association between the glucose-to-lymphocyte ratio (GLR) and all-cause mortality in int …
501,357 results
You have reached the last available page of results. Please see the User Guide for more information.